Darling Ingredients (DAR) Earns Daily Media Sentiment Score of 0.05

Media headlines about Darling Ingredients (NYSE:DAR) have trended somewhat positive on Wednesday, according to Accern. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Darling Ingredients earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.6370101387307 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

These are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

A number of research analysts recently weighed in on DAR shares. J P Morgan Chase & Co cut shares of Darling Ingredients from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $19.00 to $18.00 in a report on Friday, October 6th. BidaskClub upgraded shares of Darling Ingredients from a “buy” rating to a “strong-buy” rating in a report on Thursday, July 6th. Zacks Investment Research upgraded shares of Darling Ingredients from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 18th. Robert W. Baird restated an “outperform” rating and issued a $20.00 price objective on shares of Darling Ingredients in a report on Wednesday, August 23rd. Finally, Canaccord Genuity restated a “buy” rating and issued a $18.00 price objective on shares of Darling Ingredients in a report on Monday, September 25th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $18.40.

Darling Ingredients (DAR) opened at 16.71 on Wednesday. The firm has a market cap of $2.75 billion, a PE ratio of 32.83 and a beta of 1.57. The firm’s 50-day moving average is $17.58 and its 200 day moving average is $16.18. Darling Ingredients has a 12-month low of $11.51 and a 12-month high of $18.65.

Darling Ingredients (NYSE:DAR) last issued its quarterly earnings data on Wednesday, August 9th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by ($0.05). Darling Ingredients had a net margin of 2.39% and a return on equity of 3.99%. The firm had revenue of $896.30 million during the quarter, compared to analyst estimates of $890.91 million. During the same period last year, the business earned $0.19 EPS. The firm’s revenue was up 2.2% compared to the same quarter last year. Equities research analysts predict that Darling Ingredients will post $0.40 EPS for the current year.

WARNING: This article was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://www.com-unik.info/2017/10/11/darling-ingredients-dar-earns-daily-media-sentiment-score-of-0-05.html.

Darling Ingredients Company Profile

Darling Ingredients Inc (Darling) is a developer and producer of sustainable natural ingredients from edible and inedible bio-nutrients, creating a range of ingredients and customized specialty solutions for customers in the pharmaceutical, food, pet food, feed, industrial, fuel, bioenergy and fertilizer industries.

Insider Buying and Selling by Quarter for Darling Ingredients (NYSE:DAR)

What are top analysts saying about Darling Ingredients Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Darling Ingredients Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit